Back to search
FDAFDA · Food and drugs·Recall number D-0219-2026

Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56

Published December 17, 2025 · Recall initiated: November 11, 2025

Summary

FDA records drug Class III recall D-0219-2026, published December 17, 2025 and initiated November 11, 2025. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 4800 54-count bottles; Lot: Lot # F2400244, Exp Date: 10/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

What to do

Voluntary: Firm initiated · Letter

Get an email if VARENICLINE TARTRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VARENICLINE TARTRATE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Distributed Nationwide
Lot
Lot # F2400244, Exp Date: 10/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56 recalled?

Yes. FDA published recall D-0219-2026 on December 17, 2025. Reported hazard: Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VARENICLINE TARTRATE.